Avantor Q2 FY2026 Earnings Call
With Emmanuel Ligner (President and CEO) and Steven Eck (Senior VP, Interim CFO, and Chief Accounting Officer).
Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.
More about Avantor
Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.
1Prepared remarks3 speakers
Thank you, operator. Good morning, everyone, and thank you for joining us. Our speakers today are Emmanuel Ligner, President and Chief Executive Officer, and Steven Eck, Senior Vice President, Interim Chief Financial Officer, and Chief Accounting Officer. The press release and our presentation accompanying this call are available on our investor relations website at ir.avantorsciences.com. Following our prepared remarks, we'll open the call for questions. A replay of the call will be made available on our website…
Thank you, Chris, and good morning, everyone. Thank you for joining our call today. I will begin with a high-level update on our second quarter performance. I will then reflect on the actions we've taken since I came into this role nearly 12 months ago and discuss the progress we are making in executing Revival, our comprehensive program to sharpen strategic focus and improve execution. Turning to slide four, let me highlight a few key messages. First, we remain highly focused on executing Revival, and I'm very…
Thank you, Emmanuel, and good morning, everyone. Please turn to slide 10, where I will review our consolidated financial results. In Q2, we generated $1.69 billion of revenue, which declined -0.4% on an organic basis and was up +0.5% on a reported basis. Adjusted EBITDA was $254 million, resulting in a margin of 15%, and adjusted earnings per share of $0.21. Free cash flow for the quarter was $143 million. Excluding cash restructuring costs, free cash flow was $152 million. Both figures were ahead of expectations…
Thank you, Steve. In closing, on slide 15, I would like to leave you with three key takeaways. First, nine months into Revival, the operational changes we have implemented are delivering measurable results. Those improvements are increasingly evident in our operating and financial performance and reinforce the positive trajectory…